Tag: Windtree Therapeutics
Using genetics to guide treatment of arterial hypertension with Rostafuroxin
Primary hypertension is a major health concern and can cause serious cardiac, renal and brain complications responsible for about 10% of worldwide health burden and costs. The development of hypertension is triggered by genetic factors that, in turn, are modulated by biological and environmental factors. Many drugs are available for the treatment of hypertension, but none target the underlying genetic […]
Read More… from Using genetics to guide treatment of arterial hypertension with Rostafuroxin